Responses
Abstracts Accepted for Publication
Rheumatoid arthritis - anti-TNF therapy
AB0334 Clinical Efficacy of Certolizumab Pegol Therapy in Patients with Japanese Active Rheumatoid Arthritis 52 Week Result ∼A Multicenter Registry Study∼
Compose a Response to This Article
Other responses
No responses have been published for this article.